Efficacy Study of Inecalcitol in Combination with Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy - ICT-8-Studie
Projektleiter:
Finanzierung:
Industrie;
To evaluate the effect of the addition of inecalcitol to decitabine treatment on overall survival in previously untreated AML patients 65 years or more who are randomly assigned to receive decitabine with or without inecalcitol.
Evaluate the effect of the addition of inecalcitol to decitabine treatment on overall survival in previously untreated AML patients aged 65 years or more who are randomly assigned to receive decitabine with or without inecalcitol.
Evaluate the effect of the addition of inecalcitol to decitabine treatment on overall survival in previously untreated AML patients aged 65 years or more who are randomly assigned to receive decitabine with or without inecalcitol.
Kontakt
Prof. Dr. med. Haifa Kathrin Al-Ali
Martin-Luther-Universität Halle-Wittenberg
Universitätsklinik und Poliklinik für Innere Medizin IV
Ernst-Grube-Straße 40
06120
Halle (Saale)
Tel.:+49 345 5577002
weitere Projekte
Die Daten werden geladen ...